» Articles » PMID: 21470209

Review of Gastric Cancer Risk Factors in Patients with Common Variable Immunodeficiency Disorders, Resulting in a Proposal for a Surveillance Programme

Overview
Date 2011 Apr 8
PMID 21470209
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Common variable immunodeficiency disorders (CVIDs) are the most frequent symptomatic primary immunodeficiencies in adults. They comprise a heterogeneous group of pathologies, with frequent non-infectious complications in addition to the bacterial infections that usually characterize their presentation. Complications include a high risk of malignancy, especially lymphoma and gastric cancer. Helicobacter pylori infection and pernicious anaemia are risk predictors for gastric cancer in the general population and probably in patients with CVIDs. Screening for gastric cancer in a high-risk population appears to improve survival. Given the increased risk of gastric cancer in patients with CVIDs and prompted by a case of advanced gastric malignancy in a patient with a CVID and concomitant pernicious anaemia, we performed a review of the literature for gastric cancer and conducted a cohort study of gastric pathology in 116 patients with CVIDs under long-term follow-up in Oxford. Regardless of the presence of pernicious anaemia or H. pylori infection, patients with CVIDs have a 10-fold increased risk of gastric cancer and are therefore a high-risk population. Although endoscopic screening of all patients with CVIDs could be considered, a more selective approach is appropriate and we propose a surveillance protocol that should reduce modifiable risk factors such as H. pylori, in order to improve the management of patients with CVIDs at risk of gastric malignancy.

Citing Articles

Cancer Trends in Inborn Errors of Immunity: A Systematic Review and Meta-Analysis.

Fekrvand S, Abolhassani H, Esfahani Z, Fard N, Amiri M, Salehi H J Clin Immunol. 2024; 45(1):34.

PMID: 39466473 DOI: 10.1007/s10875-024-01810-w.


CVID-Associated Intestinal Disorders in the USIDNET Registry: An Analysis of Disease Manifestations, Functional Status, Comorbidities, and Treatment.

Franzblau L, Fuleihan R, Cunningham-Rundles C, Wysocki C J Clin Immunol. 2023; 44(1):32.

PMID: 38133694 DOI: 10.1007/s10875-023-01604-6.


High Expression of COL10A1 Is an Independent Predictive Poor Prognostic Biomarker and Associated with Immune Infiltration in Advanced Gastric Cancer Microenvironment.

Shen N, Zhu S, Zhang Z, Yong X J Oncol. 2022; 2022:1463316.

PMID: 36276283 PMC: 9584694. DOI: 10.1155/2022/1463316.


Diagnostic Challenges in Patients with Inborn Errors of Immunity with Different Manifestations of Immune Dysregulation.

Pieniawska-Smiech K, Pasternak G, Lewandowicz-Uszynska A, Jutel M J Clin Med. 2022; 11(14).

PMID: 35887984 PMC: 9324612. DOI: 10.3390/jcm11144220.


Contribution of to the Inflammatory Complications of Common Variable Immunodeficiency.

Motta-Raymundo A, Rosmaninho P, Santos D, Ferreira R, P Silva S, Ferreira C Front Immunol. 2022; 13:834137.

PMID: 35711410 PMC: 9193800. DOI: 10.3389/fimmu.2022.834137.


References
1.
Daniels J, Lederman H, Maitra A, Montgomery E . Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007; 31(12):1800-12. DOI: 10.1097/PAS.0b013e3180cab60c. View

2.
Yap Y, So J . Gastric adenocarcinoma occurring in a young patient with common variable immunodeficiency syndrome. Singapore Med J. 2009; 50(6):e201-3. View

3.
Mera R, Fontham E, Bravo L, Bravo J, Piazuelo M, Camargo M . Long term follow up of patients treated for Helicobacter pylori infection. Gut. 2005; 54(11):1536-40. PMC: 1462952. DOI: 10.1136/gut.2005.072009. View

4.
Lamers C, Jansen J . Hypogammaglobulinaemia and gastric cancer. Lancet. 1985; 1(8437):1100-1. DOI: 10.1016/s0140-6736(85)92399-2. View

5.
Wilson J, Jungner Y . [Principles and practice of mass screening for disease]. Bol Oficina Sanit Panam. 1968; 65(4):281-393. View